• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Urologix, Inc. (ULGX)

    -Other OTC
    0.08 Up 0.00(0.13%) Sep 1, 9:30AM EDT
    Add to Portfolio
    Prev Close:0.07
    Open:0.08
    Bid:N/A
    Ask:N/A
    1y Target Est:1.50
    Beta:1.1617
    Next Earnings Date:N/A
    Day's Range:0.08 - 0.08
    52wk Range:0.04 - 0.17
    Volume:1,000
    Avg Vol (3m):9,438
    Market Cap:1.60M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ULGXUp 0.13%1.60M
    LMNS 0.00%500.97M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from benign prostatic hyperplasia (BPH). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback